Portal de Periódicos da CAPES

THE INITIAL DEACTIVATION OF PHENELZINE BY A MONOAMINE OXIDASE‐LIKE SYSTEM IN VITRO AND IN VIVO

1965; Wiley; Volume: 24; Issue: 1 Linguagem: Inglês

10.1111/j.1476-5381.1965.tb02100.x

2056-8177

A. Horita,

Chemical Reaction Mechanisms

British Journal of Pharmacology and ChemotherapyVolume 24, Issue 1 p. 245-252 Free Access THE INITIAL DEACTIVATION OF PHENELZINE BY A MONOAMINE OXIDASE-LIKE SYSTEM IN VITRO AND IN VIVO A. HORITA, A. HORITA Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98105, U.S.A.Search for more papers by this author A. HORITA, A. HORITA Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98105, U.S.A.Search for more papers by this author First published: February 1965 https://doi.org/10.1111/j.1476-5381.1965.tb02100.xCitations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES Blaschko, H. (1952). Amine[oxidase and amine]metabolism. Pharmacol. Rev., 4, 415– 458. Chessin, M., Dubnick, B., Leeson, G. & Scott, C. C. (1959). Biochemical and pharmacological studies of β-phenylethylhydrazine and selected related compounds. Ann. N.Y. Acad. Sci., 80, 597– 608. Horita, A. (1961). The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition. Toxicol. appl. Pharmacol., 3, 474– 480. Horita, A. (1963). The influence of drug-tissue interactions on the inhibition of monoamine oxidase by pheniprazine and iproniazid. J. Pharmacol. exp. Ther., 142, 141– 146. Horita, A. & McGrath, W. R. (1960a). Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines. Proc. Soc. exp. Biol. (N.Y.), 103, 753– 757. Horita, A. & McGrath, W. R. (1960b). The interaction between reversible and irreversible monoamine oxidase inhibitors. Biochem. Pharmacol., 3, 206– 211. Kory, M. & Mingioli, E. (1964). Volatile amine oxidase inhibitor from hydrazine derivatives. Biochem. Pharmacol., 13, 577– 588. Leverett, R., Leeson, G. A. & Dubnick, B. (1960). Metabolism of β-phenethylhydrazine. II: Biotransformation. Abstr. Amer. Chem. Soc., Sept. 1960, p. 65C. Smith, T. E., Weissbach, H. & Udenfriend, S. (1963). Studies on monoamine oxidase: The mechanism of inhibition of monoamine oxidase by iproniazid. Biochemistry, 2, 746– 751. Udenfriend, S., Weissbach, H. & Brodie, B. B. (1958). Assay of serotonin and related metabolites, enzymes and drugs. Meth. biochem. Anal., 6, 95– 130. Zeller, E. A., Barsky, J. & Berman, E. R. (1955). Amine oxidases. XI. Inhibition of monoamine oxidase by 1-isonicotinyl-2-isopropyl-hydrazine. J. biol. Chem., 214, 267– 274. Citing Literature Volume24, Issue1February 1965Pages 245-252 ReferencesRelatedInformation